Parkwood »

SPDR S&P Biotech shares owned by Parkwood

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Parkwood from 13F filings

Historical chart of Parkwood investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Parkwood consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Parkwood

Quarter filed Position value Share count Share price at filing
2023-03-31 $72M 9.5k 7621.05
2022-12-31 $79M 950k 83.00
2022-09-30 $75M 950k 79.32

More positions owned by Parkwood

Vanguard Total Stock Mkt Etf Etp (VTI)
Ishares Russell 2000 Etf Etp Put Option (IWM)
Spdr S&p 500 Etf Trust Etp Put Option (SPY)
Spdr Bloomberg 1-3 Month T-b Etp (BIL)
Kraneshares Csi China Intern Etp Call Option (KWEB)
Ishares 20 Year Treasury Bo Etp Call Option (TLT)
Roblox Corp -class A Common Stock (RBLX)
Vanguard Ftse Emerging Marke Etp (VWO)
Ark Innovation Etf Etp (ARKK)
Totalenergies Se - Adr (TTE)
Elevance Health Common Stock (ELV)
Canadian Natural Resources Common Stock (CNQ)
Vanguard Tot World Stk Etf Etp (VT)
Apollo Global Management Common Stock (APO)
Novo-nordisk A/s-spons Adr (NVO)

View all positions for Parkwood

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Citadel Advisors
Millennium Management
UBS Group
Bank of America Corporation
Citigroup
venBio Select Advisor
Jpmorgan Chase & Co
Nantahala Capital Management
Healthcare Of Ontario Pension Plan Trust Fund
Moore Capital Management
Barclays
Perceptive Advisors
Gts Securities
Brown Advisory Holdings Incorporated

View all funds holding SPDR S&P Biotech